These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy. Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of the growth and survival of recombinant Mycobacterium smegmatis expressing Mce4A and Mce4E from Mycobacterium bovis. He L; Zhou X; Yin X; Tian L; Yang L; Fan K; Zhao D DNA Cell Biol; 2015 Feb; 34(2):125-32. PubMed ID: 25536284 [TBL] [Abstract][Full Text] [Related]
9. MmpS5/MmpL5 as an efflux pump in Mycobacterium species. Briffotaux J; Huang W; Wang X; Gicquel B Tuberculosis (Edinb); 2017 Dec; 107():13-19. PubMed ID: 29050760 [TBL] [Abstract][Full Text] [Related]
10. Role of glutathione in macrophage control of mycobacteria. Venketaraman V; Dayaram YK; Amin AG; Ngo R; Green RM; Talaue MT; Mann J; Connell ND Infect Immun; 2003 Apr; 71(4):1864-71. PubMed ID: 12654802 [TBL] [Abstract][Full Text] [Related]
11. Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Milano A; Pasca MR; Provvedi R; Lucarelli AP; Manina G; Ribeiro AL; Manganelli R; Riccardi G Tuberculosis (Edinb); 2009 Jan; 89(1):84-90. PubMed ID: 18851927 [TBL] [Abstract][Full Text] [Related]
12. Differences in nitrate reduction between Mycobacterium tuberculosis and Mycobacterium bovis are due to differential expression of both narGHJI and narK2. Sohaskey CD; Modesti L FEMS Microbiol Lett; 2009 Jan; 290(2):129-34. PubMed ID: 19076631 [TBL] [Abstract][Full Text] [Related]
13. Potential of Mycobacterium vanbaalenii as a model organism to study drug transporters of Mycobacterium tuberculosis, Mycobacterium marinum and Mycobacterium ulcerans: homology analysis of M. tuberculosis drug transporters among mycobacterial species. Gupta AK; Katoch VM; Chauhan DS; Lavania M Infect Genet Evol; 2012 Jun; 12(4):853-6. PubMed ID: 22127144 [TBL] [Abstract][Full Text] [Related]
14. The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines. Florio W; Brancatisano FL; Bottai D; Esin S; Di Luca M; Counoupas C; Maisetta G; Lupetti A; Batoni G; Campa M Can J Microbiol; 2009 Aug; 55(8):975-82. PubMed ID: 19898537 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Mycobacterium bovis double knockout mce2-phoP as candidate vaccine against bovine tuberculosis. García E; Bianco MV; Gravisaco MJ; Rocha RV; Blanco FC; Bigi F Tuberculosis (Edinb); 2015 Mar; 95(2):186-9. PubMed ID: 25620706 [TBL] [Abstract][Full Text] [Related]
16. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. De Rossi E; Aínsa JA; Riccardi G FEMS Microbiol Rev; 2006 Jan; 30(1):36-52. PubMed ID: 16438679 [TBL] [Abstract][Full Text] [Related]
17. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development. Bailo R; Bhatt A; Aínsa JA Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884 [TBL] [Abstract][Full Text] [Related]
18. Use of the Salmonella MgtR peptide as an antagonist of the Mycobacterium MgtC virulence factor. Belon C; Rosas Olvera M; Vives E; Kremer L; Gannoun-Zaki L; Blanc-Potard AB Future Microbiol; 2016; 11(2):215-25. PubMed ID: 26849775 [TBL] [Abstract][Full Text] [Related]